Cascade Prodrug, Inc. — Form D
Cascade Prodrug, Inc. of Portland, OR, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-13. The offering totals $500K, of which $350K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-06-13
- Form: D
- Accession: 0001541764-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $350K
- Remaining: $150K
- Minimum investment: $25K
- Investors: 7
- Date of first sale: 2016-06-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-264833
Issuer
- Name: Cascade Prodrug, Inc.
- CIK: 0001541764
- Entity type: Corporation
- Jurisdiction: OREGON
- Incorporated: 2009
- Address: c/o Ater Wynne LLP, Portland, OR, 97209
- Phone: (541) 343-6025
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Lynnor B Stevenson | Director | Portland, OR |
| Allan Cochrane | Director | Eugene, OR |
| Allan Cochrane | Executive Officer | Eugene, OR |
| Allan Cochrane | Promoter | Eugene, OR |
| August Sick | Director | Eugene, OR |
| August Sick | Executive Officer | Eugene, OR |
| August Sick | Promoter | Eugene, OR |
| Lynnor G Stevenson | Director | Eugene, OR |
| August G Sick | Director | Eugene, OR |
| August G Sick | Executive Officer | Eugene, OR |
| Allan G Cochrane | Director | Eugene, OR |
| Allan G Cochrane | Executive Officer | Eugene, OR |
| Christopher G Schelling | Director | Eugene, OR |
Other filings by this issuer (7)
More